oncgnostics GmbH Alternatives & Competitors
12 companies similar to oncgnostics GmbH — Precision in Cancer Diagnostics
Companies similar to oncgnostics GmbH
PreCyte Inc
Envisioning a world free from cancer and neurodegenerative disease
Seattle, United States
Nucleix Ltd.
Developing cancer diagnostic panels based on epigenetic bio markers
Rehovot, Israel
Valladolid, Spain
Beacon Biomedical
Easy, Accurate & Affordable Blood Based Screening for early detection of cancer and COVID-...
Phoenix, United States
Track all oncgnostics GmbH competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Singlera Genomics Incorporated
Detect cancer earlier with the power of circulating tumor methylated DNA (ctmDNA).
La Jolla, United States
LungLife AI
LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analys...
Thousand Oaks, United Sta...
Aidian
Aidian develops, manufactures and markets diagnostic tests and test solutions.
Espoo, Finland
Portugal
Sunbird Bio
Unparalleled leader in protein-based diagnostic tests, empowering researchers and clinicia...
Cambridge, United States
Harae Dx Corp.
Harae Dx is developing the worlds first low-cost portable Automated cancer detection syste...
Pleasanton, United States
Mainz Biomed
Saving lives through innovative molecular diagnostic solutions.
Mainz, Germany
About oncgnostics GmbH
Oncgnostics GmbH, founded in 2012 and headquartered in Germany, is gaining traction in the biotechnology sector under its slogan, "Precision in Cancer Diagnostics." The company specializes in developing molecular in vitro diagnostic (IVD) tests utilizing proprietary epigenetic biomarkers. This innovative approach aims...
Entwicklung von molekulardiagnostischen Tests, Früherkennung und Diagnose von Krebs mittels Biomarkern, Klinische Validierung von diagnostischen Tests
Diagnostiklabore, Pharmaunternehmen, Krankenhäuser, Ärzte und Onkologen
Cancer Diagnostics, Epigenetic Biomarkers, In Vitro Diagnostic Tests, PCR-based Technologies, Molecular Diagnostics, Cervical Cancer Detection, DNA Methylation, Assay Development, Routine Molecular Diagnostics, Screening Tests, Therapeutic Decision-Making, Follow-up Care, Precancerous Lesions Detection
B2B2C, B2B, White Label
Product Sales, Licensing, Usage Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches oncgnostics GmbH and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at oncgnostics GmbH on 14 May 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
